X0508 4 2024-03-15 0001880438 AN2 Therapeutics, Inc. ANTX 0001949621 Eizen Joshua M C/O AN2 THERAPEUTICS, INC. 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 true Chief Legal Officer false Common Stock 2024-03-15 4 A 0 30000 0 A 32447 D Stock Option (right to buy) 3 2024-03-15 4 A 0 60000 0 A 2034-03-14 Common Stock 60000 60000 D These restricted stock units vest as follows: 1/16th of the shares vests quarterly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date. Reflects the adjusted total which includes the purchase of 1,207 shares under the AN2 Therapeutics, Inc. 2022 Employee Stock Purchase Plan on March 31, 2023. Reflects the adjusted total which includes the purchase of 1,240 shares under the AN2 Therapeutics, Inc. 2022 Employee Stock Purchase Plan on September 29, 2023. The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date. /s/ Lucy Day, Attorney-in-Fact for Joshua M. Eizen 2024-03-18